387453004: Dipotassium clorazepate (substance)

SNOMED CT Concept\Substance\...

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Central nervous system agent (substance)\...

\Psychoactive substance (substance)\Psychotropic agent (substance)\Hypnotic AND/OR sedative (substance)\Sedative (substance)\Benzodiazepine (substance)\Benzodiazepine sedative (substance)\Dipotassium clorazepate
\Psychoactive substance (substance)\Psychotropic agent (substance)\Hypnotic AND/OR sedative (substance)\Hypnotic agent (substance)\Benzodiazepine (substance)\Benzodiazepine sedative (substance)\Dipotassium clorazepate
\Psychoactive substance (substance)\Psychotropic agent (substance)\Anxiolytic, sedative AND/OR hypnotic (substance)\Anxiolytic agent (substance)\Benzodiazepine (substance)\Benzodiazepine sedative (substance)\Dipotassium clorazepate
\Psychoactive substance (substance)\Psychotropic agent (substance)\Anxiolytic, sedative AND/OR hypnotic (substance)\Sedative (substance)\Benzodiazepine (substance)\Benzodiazepine sedative (substance)\Dipotassium clorazepate
\Psychoactive substance (substance)\Psychotropic agent (substance)\Anxiolytic, sedative AND/OR hypnotic (substance)\Hypnotic agent (substance)\Benzodiazepine (substance)\Benzodiazepine sedative (substance)\Dipotassium clorazepate
\Psychoactive substance (substance)\Central depressant\Sedative (substance)\Benzodiazepine (substance)\Benzodiazepine sedative (substance)\Dipotassium clorazepate

\Anticonvulsant\Benzodiazepine (substance)\Benzodiazepine sedative (substance)\Dipotassium clorazepate

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\Organic compound\Organic cyclic compound\Heterocyclic compound\Benzazepine (substance)\Benzodiazepine (substance)\Benzodiazepine sedative (substance)\Dipotassium clorazepate

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Dipotassium clorazepate	Is a	Clorazepate	false	Inferred relationship	Some
Dipotassium clorazepate	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	Clorazepate	true	Inferred relationship	Some
Dipotassium clorazepate	Is a	Benzodiazepine sedative (substance)	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
forgiftning med kaliumclorazepat	Causative agent	False	Dipotassium clorazepate	Inferred relationship	Some	1
accidentel forgiftning med kaliumclorazepat	Causative agent	False	Dipotassium clorazepate	Inferred relationship	Some
tilsigtet forgiftning med kaliumclorazepat	Causative agent	False	Dipotassium clorazepate	Inferred relationship	Some
forgiftning med kaliumclorazepat, uvist med hvilken hensigt	Causative agent	False	Dipotassium clorazepate	Inferred relationship	Some	1
bivirkning af kaliumclorazepat	Causative agent	False	Dipotassium clorazepate	Inferred relationship	Some	1
allergi over for kaliumclorazepat	Causative agent	False	Dipotassium clorazepate	Inferred relationship	Some
accidentel overdosis af kaliumclorazepat	Causative agent	False	Dipotassium clorazepate	Inferred relationship	Some	1
Dipotassium clorazepate 7.5 mg oral capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Dipotassium clorazepate	Inferred relationship	Some
Dipotassium clorazepate 15 mg oral capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Dipotassium clorazepate	Inferred relationship	Some
Product containing precisely dipotassium clorazepate 7.5 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Dipotassium clorazepate	Inferred relationship	Some
Dipotassium clorazepate 15 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Dipotassium clorazepate	Inferred relationship	Some
Dipotassium clorazepate 11.25 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Dipotassium clorazepate	Inferred relationship	Some
Clorazepate dipotassium 7.5mg	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Dipotassium clorazepate	Inferred relationship	Some
Product containing precisely dipotassium clorazepate 22.5 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Dipotassium clorazepate	Inferred relationship	Some
Product containing precisely dipotassium clorazepate 3.75 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Dipotassium clorazepate	Inferred relationship	Some
clorazepatdikalium	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Dipotassium clorazepate	Inferred relationship	Some
accidentel forgiftning med kaliumclorazepat	Causative agent	False	Dipotassium clorazepate	Inferred relationship	Some	1
tilsigtet forgiftning med kaliumclorazepat	Causative agent	False	Dipotassium clorazepate	Inferred relationship	Some	1
allergi over for kaliumclorazepat	Causative agent	False	Dipotassium clorazepate	Inferred relationship	Some	1
Chlorazepate dipotassium measurement	Component	True	Dipotassium clorazepate	Inferred relationship	Some	1
Dipotassium clorazepate 7.5 mg oral capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Dipotassium clorazepate	Inferred relationship	Some	1
Dipotassium clorazepate 7.5 mg oral capsule	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Dipotassium clorazepate	Inferred relationship	Some	1
Dipotassium clorazepate 15 mg oral capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Dipotassium clorazepate	Inferred relationship	Some	1
Dipotassium clorazepate 15 mg oral capsule	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Dipotassium clorazepate	Inferred relationship	Some	1
Product containing precisely dipotassium clorazepate 7.5 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Dipotassium clorazepate	Inferred relationship	Some	1
Product containing precisely dipotassium clorazepate 7.5 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Dipotassium clorazepate	Inferred relationship	Some	1
Dipotassium clorazepate 15 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Dipotassium clorazepate	Inferred relationship	Some	1
Dipotassium clorazepate 15 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Dipotassium clorazepate	Inferred relationship	Some	1
Dipotassium clorazepate 11.25 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Dipotassium clorazepate	Inferred relationship	Some	1
Dipotassium clorazepate 11.25 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Dipotassium clorazepate	Inferred relationship	Some	1
Product containing precisely dipotassium clorazepate 22.5 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Dipotassium clorazepate	Inferred relationship	Some	1
Product containing precisely dipotassium clorazepate 22.5 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Dipotassium clorazepate	Inferred relationship	Some	1
Product containing precisely dipotassium clorazepate 3.75 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Dipotassium clorazepate	Inferred relationship	Some	1
Product containing precisely dipotassium clorazepate 3.75 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Dipotassium clorazepate	Inferred relationship	Some	1
Dipotassium clorazepate 7.5 mg oral capsule	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Dipotassium clorazepate	Inferred relationship	Some	1
Dipotassium clorazepate 15 mg oral capsule	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Dipotassium clorazepate	Inferred relationship	Some	1
Product containing precisely dipotassium clorazepate 22.5 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Dipotassium clorazepate	Inferred relationship	Some	1
Product containing precisely dipotassium clorazepate 7.5 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Dipotassium clorazepate	Inferred relationship	Some	1
Dipotassium clorazepate 15 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Dipotassium clorazepate	Inferred relationship	Some	1
Dipotassium clorazepate 11.25 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Dipotassium clorazepate	Inferred relationship	Some	1
Product containing precisely dipotassium clorazepate 3.75 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Dipotassium clorazepate	Inferred relationship	Some	1
Allergy to dipotassium clorazepate	Causative agent	False	Dipotassium clorazepate	Inferred relationship	Some	1

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
1481544013	Clorazepate dipotassium	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
2476900012	Dipotassium clorazepate	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3494518012	Dipotassium clorazepate (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3180371000005118	clorazepatdikalium	da	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	Danish module (core metadata concept)